HDRPF Stock Chart & Stats
$0.01
<$0.01(614.29%)
At close: 4:00 PM EDT
$0.01
<$0.01(614.29%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume1.00K
Average Volume (3M)N/A
Market Cap
$6.72M
Enterprise Value$22.62
Total Cash (Recent Filing)$242.86K
Total Debt (Recent Filing)$10.35M
Price to Earnings (P/E)―
Beta1.04
Next Earnings
Sep 02, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding389,104,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.16
Price to Book (P/B)6.55
Price to Sales (P/S)1.33
P/FCF Ratio-3.80
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue ReboundThe sharp revenue rebound indicates improved demand, customer activity or commercial execution. Sustaining this higher revenue base over the next several quarters could improve operating leverage and provide a foundation for eventual profitability.
Improving Loss TrajectoryAlthough earnings remain negative, a narrowing loss profile is constructive because it suggests operating performance is moving in the right direction. Continued improvement could reduce funding needs and strengthen the path toward break-even.
Positive Gross ProfitPositive gross profit shows that revenue is exceeding direct production or service costs, an important base for business viability. If maintained while overheads are controlled, this gross-profit platform could support future margin expansion.
Bears Say
Sharp Leverage IncreaseThe step-up in leverage materially reduces financial flexibility and increases exposure to refinancing, covenant and interest burdens. With equity shrinking, the company has less balance-sheet capacity to absorb setbacks or fund growth internally.
Persistent Cash BurnRecurring negative operating and free cash flow means the business is not yet self-funding its operations. Continued cash consumption may require external capital or additional borrowing, creating greater execution and dilution risk alongside higher leverage.
Unproven Sustainable ProfitabilityThe company has not yet demonstrated sustainable earnings power despite stronger revenue and improved losses. Persistent operating deficits can constrain reinvestment, weaken resilience and delay the point at which cash generation becomes internally funded.
Epsilon Healthcare Limited News
HDRPF FAQ
What was Epsilon Healthcare Limited’s price range in the past 12 months?
Epsilon Healthcare Limited lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Epsilon Healthcare Limited’s market cap?
Epsilon Healthcare Limited’s market cap is $6.72M.
When is Epsilon Healthcare Limited’s upcoming earnings report date?
Epsilon Healthcare Limited’s upcoming earnings report date is Sep 02, 2026 which is in 5 days.
How were Epsilon Healthcare Limited’s earnings last quarter?
Epsilon Healthcare Limited released its earnings results on Feb 27, 2026. The company reported $0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is Epsilon Healthcare Limited overvalued?
According to Wall Street analysts Epsilon Healthcare Limited’s price is currently Overvalued.
Does Epsilon Healthcare Limited pay dividends?
Epsilon Healthcare Limited does not currently pay dividends.
What is Epsilon Healthcare Limited’s EPS estimate?
Epsilon Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Epsilon Healthcare Limited have?
Epsilon Healthcare Limited has 389,104,000 shares outstanding.
What happened to Epsilon Healthcare Limited’s price movement after its last earnings report?
Epsilon Healthcare Limited reported an EPS of $0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Epsilon Healthcare Limited?
Currently, no hedge funds are holding shares in HDRPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Epsilon Healthcare Limited Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
84.04%
Trailing 12-Months
Company Description
Epsilon Healthcare Limited
Epsilon Healthcare Limited operates as an Australian-based healthcare and pharmaceutical firm, with significant operations also extending into Canada. Established in 2016 and headquartered in Sydney, the company specializes in several areas: manufacturing and distributing a range of hydroponic supplies, including equipment, materials, and vital nutrients; developing and providing medicinal cannabis products; and offering comprehensive, ready-to-implement solutions for cannabis cultivation. The company officially rebranded from THC Global Group Limited to Epsilon Healthcare Limited in February 2021.
Technical Analysis
Vita Life Sciences Limited
―
Little Green Pharma Ltd.
―
Medical Developments International Limited
―
Althea Group Holdings Ltd.
―
IDT Australia Limited
―